Literature DB >> 18651045

Endothelial dysfunction: Possible mechanisms and ways of correction.

Vadim Sagach1, Alexander Bondarenko, Olga Bazilyuk, Anatoliy Kotsuruba.   

Abstract

BACKGROUND: Endothelial function is impaired in atherosclerosis, hypertension, diabetes and aging, and this may be associated with an attenuated ability of endothelial cells to generate nitric oxide (NO).
OBJECTIVES: To evaluate possible alterations in endothelium-dependent relaxation in rat aortic rings, the activity of constitutive NO synthase and endothelial electrical responses to acetylcholine (Ach) in rat aorta, and the effect of one month of treatment with the angiotensin-converting enzyme inhibitor enalapril on endothelial function.
METHODS: Endothelial membrane potential was measured in excised rat aorta using the perforated patch-clamp technique. Enzyme activity was determined by measuring the rate of formation of L-citrulline from L-arginine.
RESULTS: In old rats and rats with experimental diabetes, the relaxation response to Ach and the activity of constitutive NO synthase were significantly depressed compared with control rats, and the endothelial resting membrane potential was significantly depolarized (-32.7+/-0.8 mV and -28.4+/-3.1 mV, respectively) compared with the control rats (-42.9+/-0.6 mV). The membrane potential attained during peak hyper-polarization to Ach in the arteries of diabetic and old rats (-57.6+/-1.1 mV and -55.7+/-2.1 mV, respectively) did not reach the level attained in the arteries of control rats (-63.1+/-0.6 mV). Enalapril treatment restored the relaxation response to Ach and increased the activity of constitutive NO synthase in aortic rings from diabetic and old rats.
CONCLUSIONS: Altered electrical properties of endothelial cells and attenuated NO synthase activity underpin the suppressed relaxation to Ach in aging and experimental diabetes. Enalapril treatment improves endothelium-dependent relaxation and the activity of constitutive NO synthase.

Entities:  

Keywords:  Aging; Diabetes; Endothelial dysfunction

Year:  2006        PMID: 18651045      PMCID: PMC2274861     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  16 in total

Review 1.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 2.  EDHF: new therapeutic targets?

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Pharmacol Res       Date:  2004-06       Impact factor: 7.658

3.  Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.

Authors:  M A Bennett; H Thurston
Journal:  Clin Sci (Lond)       Date:  1996-01       Impact factor: 6.124

4.  Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential.

Authors:  A Lückhoff; R Busse
Journal:  Pflugers Arch       Date:  1990-05       Impact factor: 3.657

5.  Increased activity and expression of Ca(2+)-dependent NOS in renal cortex of ANG II-infused hypertensive rats.

Authors:  S Y Chin; K N Pandey; S J Shi; H Kobori; C Moreno; L G Navar
Journal:  Am J Physiol       Date:  1999-11

Review 6.  Endothelial dysfunction and atherosclerosis.

Authors:  P M Vanhoutte
Journal:  Eur Heart J       Date:  1997-11       Impact factor: 29.983

7.  Temocapril, an angiotensin converting enzyme inhibitor, protects against diabetes-induced endothelial dysfunction.

Authors:  G M Pieper; W Siebeneich
Journal:  Eur J Pharmacol       Date:  2000-09-01       Impact factor: 4.432

Review 8.  Endothelial dysfunction in hypertension.

Authors:  P M Vanhoutte
Journal:  J Hypertens Suppl       Date:  1996-12

9.  Age-related changes in endothelium-dependent hyperpolarization in the rat mesenteric artery.

Authors:  K Fujii; S Ohmori; M Tominaga; I Abe; Y Takata; Y Ohya; K Kobayashi; M Fujishima
Journal:  Am J Physiol       Date:  1993-08

10.  Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors.

Authors:  Kenichi Goto; Koji Fujii; Yasuo Kansui; Mitsuo Iida
Journal:  Clin Exp Pharmacol Physiol       Date:  2004-09       Impact factor: 2.557

View more
  6 in total

Review 1.  Obesity as a premature aging phenotype - implications for sarcopenic obesity.

Authors:  Emily Nunan; Carson L Wright; Oluwayemisi A Semola; Madhan Subramanian; Priya Balasubramanian; Pamela C Lovern; Ibra S Fancher; Joshua T Butcher
Journal:  Geroscience       Date:  2022-04-26       Impact factor: 7.581

2.  Functions of cyclophilin A in atherosclerosis.

Authors:  Zhang Tian-Tian; Zhang Jun-Feng; Ge Heng
Journal:  Exp Clin Cardiol       Date:  2013

3.  Mechanisms involved in the aging-induced vascular dysfunction.

Authors:  Mariam El Assar; Javier Angulo; Susana Vallejo; Concepción Peiró; Carlos F Sánchez-Ferrer; Leocadio Rodríguez-Mañas
Journal:  Front Physiol       Date:  2012-05-28       Impact factor: 4.566

Review 4.  Efficacy of female rat models in translational cardiovascular aging research.

Authors:  K M Rice; J C Fannin; C Gillette; E R Blough
Journal:  J Aging Res       Date:  2014-12-31

5.  Effect of computerized cognitive training with virtual spatial navigation task during bed rest immobilization and recovery on vascular function: a pilot study.

Authors:  Nandu Goswami; Voyko Kavcic; Uros Marusic; Bostjan Simunic; Andreas Rössler; Helmut Hinghofer-Szalkay; Rado Pisot
Journal:  Clin Interv Aging       Date:  2015-02-10       Impact factor: 4.458

6.  Multispecies Probiotic Supplementation Favorably Affects Vascular Function and Reduces Arterial Stiffness in Obese Postmenopausal Women-A 12-Week Placebo-Controlled and Randomized Clinical Study.

Authors:  Monika Szulińska; Igor Łoniewski; Katarzyna Skrypnik; Magdalena Sobieska; Katarzyna Korybalska; Joanna Suliburska; Paweł Bogdański
Journal:  Nutrients       Date:  2018-11-05       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.